Overexpression of Galectin-1 and Galectin-3 in hepatocellular carcinoma

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations


Galectins (Gals) are evolutionarily conserved proteins that bind to β-galactoside containing glycans. Abnormal expression of Gals is associated with the development, progression, and metastasis of different types of cancer. Among the 11 Gals identified in humans, the roles of Gal-1 and Gal-3 have been extensively investigated in various tumors. Here, we summarize the roles of overly expressed Gal-1 and Gal-3 in the pathogenesis of hepatocellular carcinoma (HCC). The overexpression of Gal-1 and Gal-3 correlates with tumor growth, HCC cell migration and invasion, tumor aggressiveness, metastasis, and poor prognosis. A potentially promising future treatment strategy for HCC may include the combination of immunotherapy with Gal-1 inhibition. Additional research is warranted to investigate targeting Gal-1 and Gal-3 for HCC treatment.

Original languageEnglish (US)
Pages (from-to)173-179
Number of pages7
JournalLiver Research
Issue number4
StatePublished - Dec 2020


  • Cirrhosis
  • Epithelial-mesenchymal transition (EMT)
  • Fibrosis
  • Galectin-1 (Gal-1)
  • Galectin-3 (Gal-3)
  • Hepatocellular carcinoma (HCC)
  • Liver cancer
  • Metastasis
  • Non-alcoholic steatohepatitis (NASH)

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology


Dive into the research topics of 'Overexpression of Galectin-1 and Galectin-3 in hepatocellular carcinoma'. Together they form a unique fingerprint.

Cite this